Find out about the groundbreaking MDMA clinical trial for chronic nerve pain. Discover how this study aims to test the impact of MDMA compared to a placebo.
Clearance expands indication for use from 11-18 year olds to 8-21 year olds; and from 3 devices, not to exceed 4 weeks, to 1 device per week for 4 weeksCARMEL, Ind., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ...
There are approximately 700,000 total knee replacements and 500,000 shoulder arthroplasties performed annually in the Unites States for which this analgesic modality might be applicable, providing a ...